Process View
The chemical reactions and pathways resulting in many of the chemical changes of compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon. In multicellular organisms secondary metabolism is generally carried out in specific cell types, and may be useful for the organism as a whole. In unicellular organisms, secondary metabolism is often used for the production of antibiotics or for the utilization and acquisition of unusual nutrients.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "secondary metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PGK1 | phosphoglycerate kinase 1 | 0.836 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.806 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.737 | Human | |
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.707 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.701 | ||
| AKR7A3 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | 0.598 | Human | |
| AKR7A2 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | 0.537 | ||
| RHOA | ras homolog gene family, member A | 0.442 | Fly | |
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.399 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.358 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.356 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.355 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.305 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.292 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.273 | Fly | |
| XIAP | X-linked inhibitor of apoptosis | 0.241 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.201 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.157 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.141 | ||
| JUN | jun proto-oncogene | 0.106 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.095 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.080 | Fly | |
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.077 | ||
| EFNA1 | ephrin-A1 | 0.072 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.066 | ||
| ATP8 | ATP synthase F0 subunit 8 | 0.063 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.060 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.059 | Fly | |
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.059 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.057 | Fly | |
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.056 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.054 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.052 | ||
| ARRB1 | arrestin, beta 1 | 0.051 | ||
| MAPRE3 | microtubule-associated protein, RP/EB family, member 3 | 0.051 | Fly | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.050 | ||
| EGFR | epidermal growth factor receptor | 0.047 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.047 | Human | |
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.046 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.046 | Human | |
| ENO1 | enolase 1, (alpha) | 0.043 | ||
| MAPRE2 | microtubule-associated protein, RP/EB family, member 2 | 0.043 | Fly | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.041 | ||
| JUP | junction plakoglobin | 0.041 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.039 | Fly | |
| EFNA5 | ephrin-A5 | 0.038 | ||
| DSG2 | desmoglein 2 | 0.037 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.036 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.035 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.035 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.032 | Fly | |
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.029 | Human | |
| ANAPC4 | anaphase promoting complex subunit 4 | 0.028 | ||
| C6 | complement component 6 | 0.027 | ||
| EZR | ezrin | 0.027 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.027 | Fly | |
| DSP | desmoplakin | 0.024 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.024 | ||
| ZNF746 | zinc finger protein 746 | 0.023 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.023 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.023 | Fly | |
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.022 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.022 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.022 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.020 | ||
| SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.020 | ||
| EPHA7 | EPH receptor A7 | 0.020 | Fly | |
| GLYAT | glycine-N-acyltransferase | 0.019 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.019 | Fly | |
| IL1RAP | interleukin 1 receptor accessory protein | 0.018 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.018 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.018 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.018 | ||
| RAI1 | retinoic acid induced 1 | 0.018 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.016 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.016 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.015 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.015 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.015 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.015 | ||
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.015 | ||
| RAB27A | RAB27A, member RAS oncogene family | 0.014 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.014 | ||
| F9 | coagulation factor IX | 0.014 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.013 | ||
| GJB3 | gap junction protein, beta 3, 31kDa | 0.013 | ||
| CYP2A7 | cytochrome P450, family 2, subfamily A, polypeptide 7 | 0.013 | Human Rat | |
| FIBP | fibroblast growth factor (acidic) intracellular binding protein | 0.013 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.012 | ||
| HRG | histidine-rich glycoprotein | 0.012 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.012 | Human | |
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.012 | ||
| FMO4 | flavin containing monooxygenase 4 | 0.012 | Human | |
| C8A | complement component 8, alpha polypeptide | 0.012 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.012 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.011 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.011 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.011 | ||
| PTN | pleiotrophin | 0.011 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.011 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.011 | ||
| NCKIPSD | NCK interacting protein with SH3 domain | 0.011 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.011 | ||
| TGFA | transforming growth factor, alpha | 0.011 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.011 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.011 | ||
| DAO | D-amino-acid oxidase | 0.011 | ||
| GAS7 | growth arrest-specific 7 | 0.010 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.010 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.010 | ||
| TALDO1 | transaldolase 1 | 0.010 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.010 |